It is interesting to note how a range of disciplines and capabilities like bioengineering, genetic sequencing, data analytics, automation, machine learning, and AI, have come together to develop a vaccine in record time. We believe this year will be the year of transition. The pandemic has created an imperative for organizations to reconfigure their operations. It has already accelerated transformation in most industries and created opportunities to transform for others. To the extent that they do so, greater productivity will follow.